#ÀÎõÁö·ç¼ºÇǺο°, #ÀÎõÁö·ç¼ºÇǺο°Ä¡·á, #ÇÑÆ÷Áø, #ÀÎõÇÑÆ÷Áø, #Áö·ç¼ºÇǺο°Ä¡·á, #ÇÑÆ÷ÁøÄ¡·á, #ÀÎõÇÑÆ÷Áø, #ºÎõÁö·ç¼ºÇǺο°
ÀÎõÁö·ç¼ºÇǺο°,,ÀÎõÁö·ç¼ºÇǺο°Ä¡·á,,ÇÑÆ÷Áø,,ÀÎõÇÑÆ÷Áø,,Áö·ç¼ºÇǺο°Ä¡·á,,ÇÑÆ÷ÁøÄ¡·á,,ÀÎõÇÑÆ÷Áø,,ºÎõÁö·ç¼ºÇǺο°
¾È³çÇϼ¼¿ä. ÀÎõÁö·ç¼ºÇǺο° ºÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä
ÀÎõÁö·ç¼ºÇǺο° ºÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÇÑÆ÷Áø, ÆíÆòż±, µî¾ÆÅäÇÇ, ¾ÆÅäÇÇÇѾà, ż±, ¾ÆÅäÇÇÇǺÎ, °Ç¼±ÇÑÀÇ¿ø, µÎµå·¯±âÇÑÀÇ¿ø, ½É»ó¼º°Ç¼±, ¼Õ°¡¶ô¼öÆ÷, Áö·ç¼ºÇǺο°, ½ÀÁø°¡·Á¿ò, ÇÑ·©µÎµå·¯±â, Áö·çÇǺο°, Á¢Ã˼ºÇǺο°, ¾àÁø, ¿Â¸öµÎµå·¯±â, ¼Õ°¡¶ô°Ç¼±, ¼ÕÅé»ç¸¶±Í, Àü½Å½ÀÁø, ¾Æ±â¾ó±¼È«Á¶, °Ç¼ºµÎÇÇ, ÇǺλ縶±Í, ¾È¸éÈ«Á¶, ¾ÆÅäÇÇ°ü¸®µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.
¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ICT, ü¿Áø´Ü±â, º¹Àâ±³Á¤Ãß³ª, ¹Ì¼¼¾àÃÊÀڱؿä¹ý, ¹°¸®Ä¡·á, ÇÁ·Ñ·ÎÅ׶óÇÇ, EST, ¾à¹°¿ä¹ý, ÀÌ¿ÂÀüÀÚÀڱؿä¹ý, µµÀο¿ä¹ý, Ç¥Àç¿Ä¡·á, °üÀýºÀ¾àħ¿ä¹ý, ½ÃÇÁ°Ö, ºÀ¾àħ, ¸ÆÆÄ°Ë»ç, Ç÷¸Æ¾îÇ÷°Ë»ç, Àú¿¡³ÊÁö·¹ÀÌÀú, ¿Â¿Ä¡·á, ºñ¸¸Ä§, Àåħ, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù
¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼ Áø·áÁßÀÌ¸ç ¿ï»ê Áß±¸ ¼º¾Èµ¿, ºÎ»ê ºÏ±¸ ±¸Æ÷3µ¿, °æ±â ¿À»ê½Ã °íÇöµ¿, ÀÎõ Áß±¸ ¼ÛÇе¿1°¡, ÀüºÏ ÀüÁֽà ´öÁø±¸ ÁøºÏµ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¾È¾ç8µ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¾È¾ç1µ¿, ºÎ»ê ¿¬Á¦±¸ °ÅÁ¦3µ¿, °æºÏ ¾Èµ¿½Ã ³ëÇϵ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼®¼ö3µ¿, ÀüºÏ Áø¾È±º ¿ë´ã¸é, ÀÎõ ³²µ¿±¸ ¸¸¼ö5µ¿, Ãæ³² ³í»ê½Ã °¡¾ß°î¸é, °¿ø ȫõ±º ¼¼®¸é, ÀüºÏ Áø¾È±º ¾Èõ¸é, ºÎ»ê °¼±¸ õ¼ºµ¿, °æºÏ °æ»ê½Ã ¿ÍÃ̸é, °æ±â µ¿µÎõ½Ã µ¿µÎõµ¿, °æºÏ Æ÷Ç׽à ºÏ±¸ âÆ÷µ¿, °æ±â ºÎõ½Ã ¿ÀÁ¤±¸ °í°µ¿, ÃæºÏ Á¦Ãµ½Ã Á¦Ãµ¿ìü±¹»ç¼ÇÔ, °æºÏ ¿µ´ö±º ¿µ´öÀ¾, ºÎ»ê ºÎ»êÁø±¸ ´ç°¨1µ¿, Àü³² À强±º ¼»ï¸é, ÀüºÏ ÀüÁֽà ´öÁø±¸ ÀÎÈĵ¿2°¡, °æºÏ °æ»ê½Ã ³²Ãµ¸é, ÀüºÏ ±èÁ¦½Ã ±èÁ¦¿ìü±¹»ç¼ÇÔ, ÀÎõ °è¾ç±¸ ¿ëÁ¾µ¿, °æºÏ ¿µÃµ½Ã Àۻ굿, ÀÎõ ¼±¸ °¡ÁÂ3µ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼ ³»¿øÇÏ°í °è½Ê´Ï´Ù
ÀÎõÁö·ç¼ºÇǺο°Ä¡·á ãÀ¸½Ã´Â ¸¸¼öµ¿, ºÎõ, Á־ȿª, ÀÎõÁÖ¾È, Áß±¸, ³²µ¿±¸, µµÈµ¿, ÀÎõ, ÀÎõ¼±¸, ¿î¼µ¿, ¿µÈïµµ, ¸Å¼Û¸é, û¶ó, µ¿±¸, ¼Û¿ùµ¿, ¹è°ð, ¿Á·Ãµ¿, ¼®³²µ¿, ¼Û¸²µ¿, Áßµ¿, ºÀ´ãÀ¾, ÀÛÀüµ¿, ûÇе¿, Á־ȵ¿, ÆÈź¸é, ¿¬Èñµ¿, ±¸¿ùµ¿, ¸¶µµ¸é, ¼±Çе¿, ÀÎõ³íÇö, µ¿Ãᵿ, ¿ëÀ¯µµ, µ¿ÀÎõ, ºñºÀ¸é, ÇÐÀ͵¿ µî ÀÎõ Áö¿ª Áֹε鲲¼ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.
´õ »ìÆ캸±â
1. Sarre ME, Martin L, Moote W, et al. Are baths desirable in atopic dermatitis? J Eur Acad Dermatol Venereol 2015; 29:1265.
2. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 2014; 71:116.
3. Rikkers SM, Holland GN, Drayton GE, et al. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 2003; 135:297.
4. Bonnel RA, La Grenade L, Karwoski CB, Beitz JG. Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience. J Am Acad Dermatol 2003; 48:294.
5. van Zuuren EJ, Fedorowicz Z, Christensen R, et al. Emollients and moisturisers for eczema. Cochrane Database Syst Rev 2017; 2:CD012119.
6. www.accessdata.fda.gov/drugsatfda_docs/label/2017/761055lbl.pdf (Accessed on April 04, 2017).
7. Margolis DJ, Hoffstad O, Bilker W. Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults. Dermatology 2007; 214:289.
8. Schram ME, Spuls PI, Leeflang MM, et al. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012; 67:99.
9. Thaçi D, Simpson EL, Beck LA, et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet 2016; 387:40.